^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    RC198

    i
    Other names: RC198
    Associations

    News

    Trials
    Company:
    Rongchang Pharma
    Drug class:
    IL-15R agonist
    Related drugs:
    Associations

    News

    Trials
    3ms
    A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors (clinicaltrials.gov)
    P1, N=48, Active, not recruiting, RemeGen Co., Ltd. | Recruiting --> Active, not recruiting | Trial completion date: Sep 2024 --> Dec 2024 | Trial primary completion date: Jun 2024 --> Sep 2024
    Enrollment closed • Trial completion date • Trial primary completion date • Metastases
    |
    RC198
    over1year
    A Study of RC198 in Patients With Locally Advanced Unresectable/Metastatic Solid Tumours (clinicaltrials.gov)
    P1, N=48, Not yet recruiting, RemeGen Co., Ltd.
    New P1 trial • Metastases
    |
    RC198